DNA Damage Repair Defects as a Therapeutic Target in Pancreatic Cancer

In this downloadable slideset, Eileen M. O’Reilly, MD, reviews key data for PARP inhibition in pancreatic cancer

Eileen M. O'Reilly, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 13.4 MB
Released: January 17, 2019


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by an educational grant from

Related Content

Results from RTOG 1010 (trastuzumab plus chemoradiotherapy plus surgery for HER2+ esophageal cancer) from ASCO 2020, as reported by Clinical Care Options (CCO)

Released: June 2, 2020

Results from DESTINY-Gastric01 trial of trastuzumab deruxtecan for advanced HER2+ gastric/GEJ cancer from ASCO 2020, as reported by Clinical Care Options

Released: June 1, 2020

Results from DESTINY-CRC01 with trastuzumab deruxtecan in HER2+ metastatic colorectal cancer from ASCO 2020, as reported by Clinical Care Options

Released: June 1, 2020

Get a preview of key studies at ASCO 2020 from experts in both solid tumors and hematologic malignancies from Clinical Care Options

Ian W. Flinn, MD, PhD Axel Grothey Headshot Axel Grothey, MD Sara Hurvitz, MD, FACP Shaji Kumar, MD Stephen V. Liu, MD Bradley J. Monk, MD, FACS, FACOG Daniel P. Petrylak, MD Zofia Piotrowska, MD, MHS Elizabeth R. Plimack, MD, MS Farhad Ravandi, MD Manish A. Shah, MD Released: May 27, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?